Guideline for PET/CT imaging of neuroendocrine neoplasms withGa-DOTA-conjugated somatostatin receptor targeting peptides andF-DOPA

Research output: Contribution to journalJournal articleResearchpeer-review

Murat Fani Bozkurt, Irene Virgolini, Sona Balogova, Mohsen Beheshti, Domenico Rubello, Clemens Decristoforo, Valentina Ambrosini, Andreas Kjaer, Roberto Delgado-Bolton, Jolanta Kunikowska, Wim J G Oyen, Arturo Chiti, Francesco Giammarile, Stefano Fanti

PURPOSE & METHODS: Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using68Ga-DOTA-conjugated peptides, as well as18F-DOPA imaging for various neuroendocrine neoplasms.

RESULTS & CONCLUSION: The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with68Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.

Original languageEnglish
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number9
Pages (from-to)1588-1601
Number of pages14
ISSN1619-7070
DOIs
Publication statusPublished - Aug 2017

    Research areas

  • Dihydroxyphenylalanine/analogs & derivatives, Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring/chemistry, Humans, Image Interpretation, Computer-Assisted, Neuroendocrine Tumors/diagnostic imaging, Peptides/chemistry, Positron Emission Tomography Computed Tomography/methods, Practice Guidelines as Topic, Quality Control, Receptors, Somatostatin/metabolism, Tissue Distribution

ID: 194527303